NCT00160628

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Levetiracetam as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy for Bridging Purpose With a Similar Study on Caucasian Epileptic Subjects

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (planned)
• Sponsor: UCB Pharma · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: —

Summary

A Korean open-label, community-based trial assessing the efficacy and safety of levetiracetam as adjunctive therapy in partial epilepsy. Similarity with a similar study conducted in Caucasian epileptic subjects will be assessed.

Conditions

• Epilepsy, Partial

Interventions

Type	Name	Description
DRUG	Levetiracetam

Timeline

• Start date: 2004-03-01
• Primary completion: 2004-10-01
• Completion: 2004-10-01
• First posted: 2005-09-12
• Last updated: 2013-11-26